FI914504A - Substituerade 4-amino-3-pyridinoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. - Google Patents

Substituerade 4-amino-3-pyridinoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. Download PDF

Info

Publication number
FI914504A
FI914504A FI914504A FI914504A FI914504A FI 914504 A FI914504 A FI 914504A FI 914504 A FI914504 A FI 914504A FI 914504 A FI914504 A FI 914504A FI 914504 A FI914504 A FI 914504A
Authority
FI
Finland
Prior art keywords
deras
pyridinoler
substituer
amino
loweralkyl
Prior art date
Application number
FI914504A
Other languages
English (en)
Finnish (fi)
Other versions
FI914504A0 (fi
Inventor
Gregory Michael Shutske
Kevin James Kapples
John Dick Tomer
Nicholas Joseph Hrib
John Gerard Jurcak
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI914504A0 publication Critical patent/FI914504A0/fi
Publication of FI914504A publication Critical patent/FI914504A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Surface Treatment Of Glass (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI914504A 1990-09-27 1991-09-25 Substituerade 4-amino-3-pyridinoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. FI914504A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58911390A 1990-09-27 1990-09-27

Publications (2)

Publication Number Publication Date
FI914504A0 FI914504A0 (fi) 1991-09-25
FI914504A true FI914504A (fi) 1992-03-28

Family

ID=24356648

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914504A FI914504A (fi) 1990-09-27 1991-09-25 Substituerade 4-amino-3-pyridinoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.

Country Status (22)

Country Link
US (3) US5821239A (de)
EP (1) EP0477903B1 (de)
JP (1) JP3090511B2 (de)
KR (1) KR100215357B1 (de)
AT (1) ATE136297T1 (de)
AU (1) AU637720B2 (de)
CA (1) CA2052433C (de)
CZ (1) CZ282002B6 (de)
DE (1) DE69118470T2 (de)
DK (1) DK0477903T3 (de)
ES (1) ES2085940T3 (de)
FI (1) FI914504A (de)
GR (1) GR3019742T3 (de)
HU (1) HUT60247A (de)
IE (1) IE73874B1 (de)
IL (1) IL99581A (de)
NO (1) NO913778L (de)
NZ (1) NZ239935A (de)
PT (1) PT99073B (de)
TW (1) TW200462B (de)
YU (1) YU158591A (de)
ZA (1) ZA917692B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
FR2813891B1 (fr) * 2000-09-14 2005-01-14 Immunotech Sa Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
DE10102791B4 (de) * 2001-01-22 2004-04-15 Ifm Electronic Gmbh Elektrischer Meßumformer
CN1326519C (zh) * 2001-12-14 2007-07-18 诺沃挪第克公司 化合物及其降低激素-敏感性脂肪酶活性的用途
KR100443983B1 (ko) 2002-01-15 2004-08-09 삼성전자주식회사 냉장고
US8007826B2 (en) 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) * 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
MX2007010076A (es) * 2005-02-17 2007-10-16 Astellas Pharma Inc Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo.
UY32109A (es) * 2008-09-10 2010-04-30 Acorda Therapeutics Inc Métodos para utilizar composiciones de liberación sostenida de aminopiridina
CN102905532A (zh) 2010-02-09 2013-01-30 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
BR112015013675B1 (pt) 2012-12-13 2022-04-26 H. Lundbeck A/S Composição compreendendo vortioxetina e donepezil e usos dos mesmos
WO2014144801A1 (en) 2013-03-15 2014-09-18 Agenebio Inc. Methods and compositions for improving cognitive function
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
EA034167B8 (ru) 2015-05-22 2021-04-27 Эйджинбайо, Инк. Фармацевтические композиции леветирацетама пролонгированного высвобождения

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179563A (en) * 1978-05-19 1979-12-18 Warner-Lambert Company 3-Aryloxy-substituted-aminopyridines and methods for their production
US4734275A (en) * 1983-08-19 1988-03-29 Research Corporation Anti-curare agents
DE3514073A1 (de) * 1985-04-18 1986-10-23 Hoechst Ag, 6230 Frankfurt Mehrfach substituierte pyridin-1-oxide, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US4735958A (en) * 1986-12-22 1988-04-05 Warner-Lambert Company Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis
US4831044A (en) * 1987-10-29 1989-05-16 Ici Americas Inc. Fungicidal pyridyl cyclopropane carboxamidines
US4994473A (en) * 1987-11-17 1991-02-19 Ici Americas Inc. Pyridyl containing insecticides
US5019574A (en) * 1988-09-30 1991-05-28 Chugai Seiyaku Kabushiki Kaisha 3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline compounds useful for improving psychoneural function
KR0156241B1 (ko) * 1988-11-16 1998-11-16 도날드 알.토센 하이드록시-1,2,3,4-테트라하이드로아미노아크리딘, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US4931457B1 (en) * 1989-06-28 1993-11-16 Hoechst-Roussel Pharmaceuticals Incorporated Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders

Also Published As

Publication number Publication date
HUT60247A (en) 1992-08-28
FI914504A0 (fi) 1991-09-25
NO913778L (no) 1992-03-30
EP0477903B1 (de) 1996-04-03
US5869480A (en) 1999-02-09
TW200462B (de) 1993-02-21
NO913778D0 (no) 1991-09-26
JP3090511B2 (ja) 2000-09-25
ATE136297T1 (de) 1996-04-15
CA2052433C (en) 2003-04-15
YU158591A (sh) 1994-12-28
JPH04261157A (ja) 1992-09-17
PT99073A (pt) 1992-08-31
GR3019742T3 (en) 1996-07-31
IL99581A (en) 1995-07-31
PT99073B (pt) 1999-02-26
IE73874B1 (en) 1997-07-02
HU913075D0 (en) 1992-01-28
ES2085940T3 (es) 1996-06-16
KR100215357B1 (ko) 1999-08-16
CZ282002B6 (cs) 1997-04-16
NZ239935A (en) 1995-07-26
DK0477903T3 (da) 1996-07-29
EP0477903A3 (en) 1992-08-05
ZA917692B (en) 1992-05-27
CS293691A3 (en) 1992-04-15
US5821239A (en) 1998-10-13
KR920006318A (ko) 1992-04-27
DE69118470T2 (de) 1996-09-19
IL99581A0 (en) 1992-08-18
EP0477903A2 (de) 1992-04-01
IE913389A1 (en) 1992-04-08
US5866565A (en) 1999-02-02
DE69118470D1 (de) 1996-05-09
AU8475691A (en) 1992-04-02
AU637720B2 (en) 1993-06-03
CA2052433A1 (en) 1992-03-28

Similar Documents

Publication Publication Date Title
FI914504A0 (fi) Substituerade 4-amino-3-pyridinoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
GR3019468T3 (en) 4- and 6-Carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
ATE238428T1 (de) Enantioselective herstellung von pharmazeutisch aktiven sulfoxiden durch bioreduktion
FI922592A (fi) (arylalkylpiperidin-4-yl)metyl)-2a,3,4,5-tetra-hydro-1(2h)-acetnaftylen-1-oner och motsvarande foereningar, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI913502A (fi) 1-(substituerade pyridinylamino-1h -indol-5-yl-substuerade karbamater, foerfarande och mellanprdukter foer framstaellning av dessa och deras anvaendning som laekemedel.
FI924230A0 (fi) Substituerade pyridinylamino-1h-indoler, -1h-indazoler, -2h-indazoler, -benso(b)tiofener och -1,2-bensoisotiazoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI875145A (fi) Kondenserade heterocykliska tetrahydroaminokinoliner och beslaektade foereningar, en metod foer deras framstaellning och deras anvaendning som mediciner.
FI915025A0 (fi) 8-azabicyklo(3,2,1) oktylalkyltiazolidinoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ES2102774T3 (es) Indolsulfonamidas como agentes antitumorales.
ATE14436T1 (de) Organosilyl-verbindungen und ihre verwendung als fungizide.

Legal Events

Date Code Title Description
FD Application lapsed